Search results
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Bought by BNP Paribas Financial Markets
ETF DAILY NEWS· 10 hours agoBNP Paribas Financial Markets lifted its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 138.8% in the fourth quarter, according ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAmicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of “Moderate Buy” by Analysts
ETF DAILY NEWS· 2 days agoAmicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering ...
Amicus Therapeutics Inc (NASDAQ: FOLD): Down -17.32% In 2024, Outlook Remains Negative – Stocks...
Stocks Register· 2 days agoThe trading price of Amicus Therapeutics Inc (NASDAQ:FOLD) floating higher at last check on Tuesday, May 14, closing at $9.34, 3.26% higher than its previous ...
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 7 days agoThe headline numbers for Amicus Therapeutics (FOLD) give insight into how the company performed in...
Investing in Amicus Therapeutics Inc
Knox Daily· 2 days agoIn a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $75524.0 on May 01 ’24. In ...
Amicus Therapeutics Inc [NASDAQ: FOLD] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 6 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Amicus Therapeutics Inc shares valued at ...
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
Zacks· 7 days agoFree Report) reported first-quarter 2024 adjusted loss of 2 cents per share, narrower than the Zacks Consensus Estimate of a loss of 6 cents. The year-over-year improvement can be attributed ...
Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
GuruFocus.com via Yahoo Finance· 6 days agoNet Loss: Reported a net loss of $48.4M, narrowing from $52.9M year-over-year, indicating ongoing investment in growth despite reduced losses. On May 9, 2024, Amicus
This Boston Beer Analyst Turns Bullish; Here Are Top 5 Upgrades For Today. - Boston Beer Co...
Benzinga· 2 days agoPlanet Fitness shares gained 0.9% to settle at $65.56 on Monday. See how other analysts view this...
